A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
Public ClinicalTrials.gov record NCT03432533. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the noninferiority of a 6-month treatment with 210 mg romosozumab at 90 mg/mL administered subcutaneously (SC) once a month (QM) in postmenopausal women with osteoporosis either by healthcare provider (HCP) administration with prefilled syringe (PFS) or by subject self-administration with autoinjector/pen (AI/Pen)
Study identification
- NCT ID
- NCT03432533
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 283 participants
Conditions and interventions
Conditions
Interventions
Drug · Device
Eligibility (public fields only)
- Age range
- 55 Years to 90 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 6, 2018 (Actual)
- Primary completion
- Apr 11, 2019 (Actual)
- Completion
- Jan 8, 2020 (Actual)
- Last update posted
- Nov 23, 2020
2018 – 2020
United States locations
- U.S. sites
- 35
- U.S. states
- 19
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35205 | — |
| Research Site | Birmingham | Alabama | 35294 | — |
| Research Site | Huntsville | Alabama | 35801 | — |
| Research Site | Tuscaloosa | Alabama | 35406 | — |
| Research Site | Chandler | Arizona | 85224 | — |
| Research Site | Mesa | Arizona | 85213 | — |
| Research Site | Cypress | California | 90630 | — |
| Research Site | Fullerton | California | 92835 | — |
| Research Site | Glendale | California | 91206 | — |
| Research Site | Laguna Hills | California | 92653 | — |
| Research Site | Santa Maria | California | 93454 | — |
| Research Site | Tustin | California | 92780 | — |
| Research Site | Denver | Colorado | 80230 | — |
| Research Site | Golden | Colorado | 80401 | — |
| Research Site | Delray Beach | Florida | 33446 | — |
| Research Site | South Miami | Florida | 33143 | — |
| Research Site | Atlanta | Georgia | 30319 | — |
| Research Site | Atlanta | Georgia | 30342 | — |
| Research Site | Bridgeton | Missouri | 63044 | — |
| Research Site | Springfield | Missouri | 65802 | — |
| Research Site | Las Vegas | Nevada | 89148 | — |
| Research Site | Great Neck | New York | 11021 | — |
| Research Site | Charlotte | North Carolina | 28204 | — |
| Research Site | Fargo | North Dakota | 58103 | — |
| Research Site | Cincinnati | Ohio | 45242 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | Wyomissing | Pennsylvania | 19610 | — |
| Research Site | Spartanburg | South Carolina | 29303 | — |
| Research Site | Summerville | South Carolina | 29486 | — |
| Research Site | San Antonio | Texas | 78209 | — |
| Research Site | Salt Lake City | Utah | 84107 | — |
| Research Site | Chesapeake | Virginia | 23320 | — |
| Research Site | Danville | Virginia | 24541 | — |
| Research Site | Renton | Washington | 98057 | — |
| Research Site | Franklin | Wisconsin | 53132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03432533, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 23, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03432533 live on ClinicalTrials.gov.